Researchers have discovered the ExHOS nanomachine responsible for constitutive exocytosis using advanced microscopy and AI-enhanced image analysis.
Key Details
- 1International team led by Pompeu Fabra University identifies ExHOS, the nanomachine controlling constitutive exocytosis.
- 2Discovery relied on integrating multiple advanced light and electron microscopes with artificial intelligence for image analysis.
- 3ExHOS organizes seven protein assemblies into a flexible ring, mediating molecular package delivery at the cell surface.
- 4ExHOS understanding has implications for infections, rare diseases, and cancer metastasis.
- 5Microscopy and AI enabled visualization of dynamic cellular machinery previously inaccessible by traditional imaging.
Why It Matters
The use of cutting-edge imaging and AI demonstrates the evolving power of bioimaging technologies, paving the way for deeper insights into fundamental biological processes and their medical implications. This integration is directly relevant to radiology and imaging AI professionals interested in high-resolution cellular and molecular imaging advancements.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.